Literature DB >> 18648910

Effect of TGF-beta/Smad signaling on sertoli cell and possible mechanism related to complete sertoli cell-only syndrome.

Tao Sun1, Zhongcheng Xin, Zhe Jin, Yiguang Wu, Yanqing Gong.   

Abstract

The roles of TGF-beta and the interaction between TGF-beta and EGFR signaling are critical in Sertoli cell, though the knowledge about them is limited. RT-PCR was used to characterize the status of TGF-beta signaling in clinical testicular specimens with complete Sertoli cell-only syndrome (SCOS). The mouse Sertoli cell TM4 was used to investigate the interaction between TGF-beta and EGFR signaling by using mitogenic assay, luciferase assay, and western blot, while TM3 (mouse leydig cell), 3T3 (mouse embryo fibroblasts), and B82 (mouse lung fibroblasts) were selected as control. The RT-PCR assay indicated that the expression levels of TbetaRII and Smad2 in SCOS testes were upregulated compared to that in the normal controls. In the in vitro experiment, the TGF-beta1 downregulated cellular proliferation of TM3 and B82 cell (P < 0.05), but it did not changed the proliferation of TM4 and 3T3 cells (P > 0.05). On contrast, TGF-beta1 only increased the TGF response elements p3TP-lux activity significantly (P < 0.05) in Sertoli cell TM4. Also, the Western blot assay shows an obvious increase of Smad2 in TM4, 3T3, and TM3 cells after TGF-beta1 treatment while the EGFR expression level was significantly increased in TM4 cells only. In conclusion, the TGF-beta pathway and the cross-link between TGF-beta and EGFR signaling may play an important role on the dysfunction of Sertoli cells which induce germ stem cells' disappearance in SCOS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18648910     DOI: 10.1007/s11010-008-9869-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

1.  Autocrine TGFbeta supports growth and survival of human breast cancer MDA-MB-231 cells.

Authors:  Xiufen Lei; Abhik Bandyopadhyay; Thy Le; LuZhe Sun
Journal:  Oncogene       Date:  2002-10-24       Impact factor: 9.867

2.  Altered expression pattern of heat shock transcription factor, Y chromosome (HSFY) may be related to altered differentiation of spermatogenic cells in testes with deteriorated spermatogenesis.

Authors:  Yoko Sato; Kaoru Yoshida; Toshikatsu Shinka; Shiari Nozawa; Yutaka Nakahori; Teruaki Iwamoto
Journal:  Fertil Steril       Date:  2006-09       Impact factor: 7.329

3.  Activation of the epidermal growth factor (EGF) receptor induces formation of EGF receptor- and Grb2-containing clathrin-coated pits.

Authors:  Lene E Johannessen; Nina Marie Pedersen; Ketil Winther Pedersen; Inger Helene Madshus; Espen Stang
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 4.  EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization.

Authors:  Hui-Wen Lo; Sheng-Chieh Hsu; Mien-Chie Hung
Journal:  Breast Cancer Res Treat       Date:  2006-02       Impact factor: 4.872

5.  Prepubertal testis development relies on retinoic acid but not rexinoid receptors in Sertoli cells.

Authors:  Nadège Vernet; Christine Dennefeld; Florian Guillou; Pierre Chambon; Norbert B Ghyselinck; Manuel Mark
Journal:  EMBO J       Date:  2006-11-23       Impact factor: 11.598

6.  The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.

Authors:  Jerry E Chipuk; Susan C Cornelius; Nicole J Pultz; Joan S Jorgensen; Michael J Bonham; Seong-Jin Kim; David Danielpour
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

7.  A network model of early events in epidermal growth factor receptor signaling that accounts for combinatorial complexity.

Authors:  Michael L Blinov; James R Faeder; Byron Goldstein; William S Hlavacek
Journal:  Biosystems       Date:  2005-10-17       Impact factor: 1.973

8.  Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.

Authors:  Françoise Maupas-Schwalm; Catherine Robinet; Nathalie Augé; Jean-Claude Thiers; Virginie Garcia; Jean-Pierre Cambus; Robert Salvayre; Anne Nègre-Salvayre
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

Review 9.  Epidermal growth factor receptor: mechanisms of activation and signalling.

Authors:  Robert N Jorissen; Francesca Walker; Normand Pouliot; Thomas P J Garrett; Colin W Ward; Antony W Burgess
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

10.  Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation.

Authors:  Michelangelo Cordenonsi; Marco Montagner; Maddalena Adorno; Luca Zacchigna; Graziano Martello; Anant Mamidi; Sandra Soligo; Sirio Dupont; Stefano Piccolo
Journal:  Science       Date:  2007-01-18       Impact factor: 47.728

View more
  4 in total

Review 1.  Sertoli cell-only syndrome: etiology and clinical management.

Authors:  Nasrin Ghanami Gashti; Mohammad Ali Sadighi Gilani; Mehdi Abbasi
Journal:  J Assist Reprod Genet       Date:  2021-01-11       Impact factor: 3.412

2.  Expression of the TGF-beta1 system in human testicular pathologies.

Authors:  Candela R Gonzalez; María E Matzkin; Mónica B Frungieri; Claudio Terradas; Roberto Ponzio; Elisa Puigdomenech; Oscar Levalle; Ricardo S Calandra; Silvia I Gonzalez-Calvar
Journal:  Reprod Biol Endocrinol       Date:  2010-12-02       Impact factor: 5.211

Review 3.  Multiple signaling pathways in Sertoli cells: recent findings in spermatogenesis.

Authors:  Fei-Da Ni; Shuang-Li Hao; Wan-Xi Yang
Journal:  Cell Death Dis       Date:  2019-07-17       Impact factor: 8.469

4.  Islet transplantation ameliorates diabetes-induced testicular interstitial fibrosis and is associated with inhibition of TGF-β1/Smad2 pathway in a rat model of type 1 diabetes.

Authors:  Yuan-Cai Zheng; Yi-Ling Feng; Yi-Hong Wang; Li-Jun Kong; Ming-Shi Zhou; Min-Min Wu; Cheng-Yang Liu; Hua-Chun Weng; Hong-Wei Wang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.